Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals.
Silvia Molina-CarriónOscar Brochado-KithJuan González-GarcíaJuan BerenguerCristina DíezElba LlopVictor HontañónLuis Ibañez-SamaniegoMaria Luisa MontesSalvador Resino GarcíaAmanda Fernández-RodíguezMaria Ángeles Jiménez-SousaPublished in: Journal of clinical medicine (2020)
HCV eradication with all-oral DAAs was associated with an increase in telomere length in HIV/HCV-coinfected patients with advanced cirrhosis, particularly in compensated patients. This finding suggests that HCV clearance may have implications in age-related conditions in this population group.